Schroeter, Christina B. http://orcid.org/0000-0002-1391-7817
Nelke, Christopher
Stascheit, Frauke
Huntemann, Niklas
Preusse, Corinna
Dobelmann, Vera
Theissen, Lukas
Pawlitzki, Marc
Räuber, Saskia
Willison, Alice
Vogelsang, Anna
Marina, Adela Della
Hartung, Hans-Peter
Melzer, Nico
Konen, Felix F.
Skripuletz, Thomas
Hentschel, Andreas
König, Simone
Schweizer, Michaela
Stühler, Kai
Poschmann, Gereon
Roos, Andreas
Stenzel, Werner
Meisel, Andreas
Meuth, Sven G.
Ruck, Tobias
Funding for this research was provided by:
Forschungskommission of the Medical Faculty of the Heinrich Heine University Düsseldorf
Ministry of Culture and Science of North Rhine-Westphalia (PROFILNRW-2020–107-A)
Regierenden Bürgermeister von Berlin - Senatskanzlei Wissenschaft und Forschung
Bundesministerium für Bildung und Forschung
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
Article History
Received: 15 February 2024
Revised: 10 June 2024
Accepted: 10 June 2024
First Online: 18 June 2024
Declarations
:
: C.B.S., C.N., S.G.M., and T.R. have been granted a patent at the European Patent Office (EPO) relating to the use of ITIH3 as a biomarker for (assessing) disease activity in myasthenia gravis patients (application number: EP22195296.3). All other authors have nothing to report.